EUVIMEDEUVIMED entdecken
Crossref

Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany

Martin Pfohl, Franz-Werner Dippel, Karel Kostev, Sabine Fuchs, Wioletta Kotowa

Health Outcomes Research in Medicine · 2011

DOI: 10.1016/j.ehrm.2011.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Outcomes Research in Medicine, 2011. Verfasst von Martin Pfohl und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pfohl, M., Dippel, F., Kostev, K., Fuchs, S., & Kotowa, W. (2011). Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany. Health Outcomes Research in Medicine. https://doi.org/10.1016/j.ehrm.2011.02.001

Vancouver

Pfohl M, Dippel F, Kostev K, Fuchs S, Kotowa W. Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany. Health Outcomes Research in Medicine. 2011. doi:10.1016/j.ehrm.2011.02.001

BibTeX
@article{Pfohl2011,
  author = {Pfohl, Martin and Dippel, Franz-Werner and Kostev, Karel and Fuchs, Sabine and Kotowa, Wioletta},
  title = {Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany},
  journal = {Health Outcomes Research in Medicine},
  year = {2011},
  doi = {10.1016/j.ehrm.2011.02.001}
}
Kostenlos starten →